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Schizophrenia is a devastating brain disorder that affects a surprising 1 % of the 
world's population. Despite this prevalence, little is known about the molecular aspects 
of this disorder making it both difficult to diagnose and treat. Several studies have 
identified the CHL 1 gene (Close Homolog of L 1 ), sometimes referred to as CALL, as a 
risk gene for schizophrenia. CHL 1, a neural cell adhesion molecule, has major roles in 
cell migration, and the development of dendritic and axonal projections. Therefore any 
deficiency in CHL 1 may result in brain defects similar to those identified in 
schizophrenic populations. Moreover, in genetically engineered mice, studies have 
shown that deficiency of the CHL 1 gene results in altered emotional reactivity (such as 
altered fear responses) and motor coordination, reduced sensorimotor gating and 
impaired working memory and spatial-temporal integration, similar characteristics to 
those seen in patients with schizophrenia. 
The focus of this study is to assess the research literature available for CHL 1 as well as 
investigate a single point mutation in the CHL 1 sequence altering a leucine residue to a 
phenylalanine in the signal peptide of the protein (Leu1 ?Phe) in order to produce a 
functional deficit of the CHL 1 gene. This missense polymorphism has been identified 
as a risk factor for schizophrenia in Asian populations. Through this mutagenesis, we 
are able to study CHL 1 protein recruitment to the cell membrane in order to understand 
CHL 1 's role in schizophrenia at a molecular level. 
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Cell Adhesion Molecules 
Cell adhesion molecules (CAM) perform a vital role in cell to cell recognition 
particularly in the development and construction of the nervous system. These proteins 
are recruited to the surface of the cell membrane where they are capable of interacting 
with other proteins on other cells as well as the extracellular matrix (ECM) allowing the 
cells to form viable tissues and detect their surroundings. Research has shown that cell 
adhesion molecules function not only in the structural capabilities of the cell, via their 
interactions with the actin cytoskeleton, but are also involved in transduction events 
(Maness and Schachner, 2007). CAMs contribute to transduction events either directly, 
through the elicitation of signals after becoming engaged by a previous signal, or 
through a collaborative way by which they modulate the efficiency of the signal pathway. 
In this way, CAMs coordinate and regulate the structure and signaling functions of the 
cell. 
CAMs are essential to the developing nervous system. They are prevalently 
expressed on growing axons and growth cones as well as their targets thereby dictating 
the movement of axons and the connections they make. This influences the overall 
structure of the nervous system. The use of CAMs has even been implicated in gene 
and cell therapy as means to repair damages incurred by neurodegenerative diseases 
and trauma (Lavdas et al., 2011) 
CAMs can be subdivided into five main classes: cadherins, selectins, mucins, 




The immunoglobulin superfamily of CAMs (lgCAM) are calcium-independent 
transmembrane glycoproteins that include an extracellular immunoglobulin-like domain. 
There are over 765 members in the immunoglobulin superfamily making it one of the 
most diverse families of proteins in the body (Soroka et al., 2008). This superfamily is 
categorized by its typical structure consisting of an extracellular domain containing 
several immunoglobulin-like intra-chain disulfide bonded loops with conserved cysteine 
residues, a transmembrane domain, and an intracellular domain that functions to 
interact with the cell's cytoskeleton. This superfamily plays critical roles in synaptic 
specificity through the use of hetero- and homophilic interactions with proteins on other 
cells as well as roles in axon growth and axon guidance towards target regions (Furley 
et al., 1990; Walsh and Doherty, 1997). lgCAMs have been shown to be expressed in 
developing mice in sensory and motor neurons within the dorsal root ganglion as well as 
the spinal cord further implicating these molecules have a significant role in the 
developing nervous systems (Gu et al., 2015). 
L 1 CAM Family 
Within the immunoglobulin superfamily there is a subset of CAMs known as the 
L 1 family. These proteins are evolutionarily well-conserved, with a structure consisting 
of 13 distinct protein domains, typically with six immunoglobulin and five fibronectin type 
Ill domains. The six immunoglobulin-like domains occur at the end of the extracellular 
region of these proteins and each protein has a single pass transmembrane region as 
well as a short cytoplasmic tail. It was originally thought that the immunoglobulin 
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domains of L 1-type proteins belonged in the C2 set of immunoglobulin proteins; 
however, comparison with other immunoglobulin type proteins revealed that these 
domains are actually novel to the L 1-type proteins and therefore should be reclassified 
into the I set (Bateman et al., 1996; Harpaz and Chothia, 1994). The second 
immunoglobulin domain is involved in the homophilic adhesive interactions of L 1-type 
proteins (Hortsch et al., 2009; Maness and Schachner, 2007). 
The cytoplasmic domains of the L 1-type protein range from 85 to 148 residues 
and contain several conserved motifs that include the amino acid tyrosine. The ankyrin-
binding site of L 1-type proteins consists of one of these important motifs: FIGQY 
(Garver et al., 1997). When FIGQY is phosphorylated, ankyrin can no longer bind to the 
L 1-type protein (Garver et al., 1997; Whittard et al., 2006). This interaction with ankyrin 
is believed to stabilize the axonal membranes and or the intercellular connections 
(Buhusi et al., 2003). The homophilic L 1-L 1 interaction does not require the whole 
cytoplasmic domain; however, both intracellular and extracellular interactions are 
needed to influence and regulate the various functions of L 1 including Ankyrin binding 
(Guan and Maness, 2010; Hortsch et al., 1998; Hortsch et al., 2009; Ooashi and 
Kamiguchi, 2009; Wong et al., 1995). 
The L 1 family contains at least four known proteins: L 1-CAM, neurofascin, 
NrCAM (neuron-glia-related cell adhesion molecule), and CHL 1 (Close Homolog of L 1 ). 
It is believed that these four paralogs arose due to two gene duplication events that 
occurred genome wide in early chordate evolution (Kappen et al., 1989; Mualla et al., 
2013; Schughart et al., 1989). An additional two genes exist per each L 1 paralog 
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among vertebrates due to a third duplication event that occurred in the teleost lineage 
resulting in a total of eight L 1-type genes in each genome (Mualla et al., 2013). 
The vast majority of L 1-type proteins are expressed in the nervous system; 
however, they are also found in many other types of tissues. These proteins undergo 
both hetero- and homophilic interactions and are capable of acting as both their own 
ligand and receptor. Some L 1-type proteins function in fasciculation, or bundling of 
groups of axons (Schmid and Maness, 2008). All proteins within the L 1 family are 
important in the guidance and growth of neurons during the development of the nervous 
system. 
Axonal Growth and Guidance 
The correct synaptic connections made during development are of the upmost 
importance for an appropriately functioning nervous system. The disruption of axon 
guidance in both the central and peripheral nervous system during human development 
has been linked to many serious brain disorders including sensory and motor deficits as 
well as intellectual deficiencies and cognitive and social impairments (lrintchev et al., 
2004). Axon guidance relies on both chemoattraction and chemorepulsion. Developing 
axons form growth cones with CAMs on their surfaces. The CAMs are able to respond 
by growing towards target-derived signals and away from chemorepellent regions 
(Figure 1 ). A primary repulsive cue are the semaphorin proteins. Semaphorins interact 
with plexins and neuropilins on the growth cones of developing neurons causing these 
growth cones to collapse thereby ceasing axon extension (Figure 1 ). 
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The L 1-type protein CHL 1 has been shown to interact with ezrin-radixin-moesin 
(ERM) in order to mediate Sema3A-induced growth cone collapse (Schlatter et al., 
2008). The RGGKYSV sequence in the juxtamembrane portion of the cytoplasmic 
domain of CHL 1 recruits ERM to the plasma membrane. The CHL 1/ERM complex 
interacts with neuropilin-1 and may alter cytoskeletal arrangements, thereby facilitating 











Figure 1. (Top) Mechanism of axonal guidance through chemorepulsion and chemoattraction. 
(Bottom) A. Growth cone of axon without the presence of Sema3A. B. Growth cone collapse of 





CHL 1, or Close Homolog to L 1, is a cell adhesion molecule expressed 
throughout the nervous system in vertebrates. The human ortholog is known as CALL 
(Cell Adhesion Molecule L 1-Like) and is encoded by a gene present on chromosome 3 
at position 3p26 (GenBank Accession Number AC011609). Mutations within CHL 1 
have been linked to 3p- syndrome, which is characterized by mental retardation, as well 
as schizophrenia (Angeloni et al., 1999; Pratte et al., 2003). 
CHL 1 is expressed by both neurons and glial cells and has a graded expression 
pattern with a high caudal density to a low rostral expression in the deep layer neurons 
of the neocortex in developing mice (Ye et al., 2008). This is in contrast to the L 1 
protein which is expressed uniformly in the central nervous system and only in neurons 
(Montag-Sallaz et al., 2002). This supports the notion that although CHL 1 is structured 
similarly to L 1, it has a different function. In rodents, CHL 1 is expressed late during 
development around the onset of axogenesis by neurons (Holm et al., 1996). CHL 1 is 
also needed for cortical neuron migration. It is believed that CHL 1 regulates area-
specific neuronal connections in areas such as the visual and somatosensory cortex 
(Demyanenko et al., 2004). Impairments in the neuronal connections within these areas 





CHL 1 consists of 26 exons over an approximate length of 90 kb (Sakurai et al., 
2002). The basic structure of the CHL 1 protein includes an N-terminal sequence, six 
immunoglobin-like domains, 4.5 fibronectin (FN) Ill repeats, a transmembrane domain, 
and a C-terminus (Figure 2). The last portion of the FN repeats is rudimentary, 
consisting of only half of the sequence. It is hypothesized that this half repeat results 
from alternative splicing (Holm et al., 1996). 
CHL 1 also contains an RGD sequence (amino acids 185-187) within its second 
lg domain on beta strand E. It is thought that this sequence is essential for cell 
attachment and integrin binding of CHL 1 (Holm et al., 1996). Another sequence found 
in CHL 1 is the DGEA sequence (amino acids 555-558). This motif is found on beta 
strand Con the sixth lg domain and is not present in other members of the L 1 family. 















Figure 2. Domain structures of CHL 1 overview (picture courtesy of (Naus et al., 2004)). 
Signal Peptide 
The N-terminus of CHL 1 contains a signal peptide region. This sequence is a 
short peptide that mediates the targeting and translocation of the protein to the 
endoplasmic reticulum membrane. This signal is particularly important for 
transmembrane proteins and secreted proteins. The signal peptide is vital for the 
appropriate trafficking of proteins to the correct regions of the cell. 
When the nascent polypeptide emerges from the ribosome, the signal sequence 
at the N-terminus along with the engaged ribosome, known as the ribosome-nascent 
complex (RNC), interacts with the signal recognition particle (SRP). When the SRP 
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binds, translation is slowed in an event known as elongation arrest. The SRP then 
delivers the RNC to an SRP receptor (SR) near a translocon at the target membrane 
where the RNC is docked. The RNC is then transferred to the translocon machinery 
and is integrated into the lipid bilayer, or, in the case of secretory proteins, is 
translocated across the membrane to enter the secretory pathway (Akopian et al., 
2013). 
This pathway requires energy which is provided by either GTPase or ATPase 
modules that are located within the targeting machinery. The signal peptides tend to 
have three regions: a positively charged N-region, a hydrophobic H-region, and a C-
region which contains polar amino acids. The co-translational trafficking of these 
proteins minimizes the misfolding and/or aggregation of nascent proteins before they 
arrive at their destinations. This is highly advantageous for the targeted delivery of 
membrane bound proteins and secretory proteins. 
The timely recognition of signal peptides by the SRP is crucial for the accurate 
initiation of co-translational protein targeting. Amino acid substitutions within the three 
regions of the signal sequence could potentially result in slower recognition of the signal 
peptide by the SRP ultimately leading to the assortment of these proteins to the wrong 
cellular locations. When proteins are not expressed in their appropriate locations, their 
associated functions may not be properly carried out, which could lead to disease. In 
fact, many studies have shown that mutations within the signal peptide region are 
correlated to disease (Crockett et al., 2011; Huang et al., 201 0; Hussain et al., 2013; Liu 
et al., 2012; Mencarelli et al., 2012; Qin et al., 2012; Rane et al., 2010). Therefore, 
mutations within the signal peptide region of CHL 1 could potentially lead to disease. 
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CHL 1 and schizophrenia 
Deficiencies and mutations within the CHL 1 gene have been associated with 
schizophrenia. Since the CHL 1 gene is highly conserved between species, studies 
directed at understanding the relationship between CHL 1 and schizophrenia were 
mostly performed in mice. These studies have shown that mice deficient in CHL 1 have 
abnormalities in both brain morphology and behavior that mimic those of schizophrenic 
patients. 
In a study done in 2002, 24 Japanese schizophrenic patients were screened for 
mutations in the CHL 1 gene to identify schizophrenia-risk associated alleles. A 
missense polymorphism was identified within the signal peptide region of CHL 1 that had 
a significantly higher frequency in the schizophrenic population when compared to the 
general population. This polymorphism is a mutation of the amino acid leucine to a 
phenylalanine at position 17 (Sakurai et al., 2002). Further genome-wide studies have 
also marked this polymorphism as a risk factor in schizophrenia (Chen et al., 2005; 
Shaltout et al., 2013). The purpose of this study is to investigate the pathogenicity of 
this point mutation and how it may function in contributing to schizophrenia. 
Brain Morphology Differences in CHL 1 Deficient Mice 
Knocking out the CHL 1 gene in mice leads to some noticeable alterations in 
brain structure when compared to mice with normally functioning CHL 1 genes. There 
are two major regions that show abnormal neuron organization when the CHL 1 gene is 
knocked out: the hippocampus and the thalamocortex. The formation of the 
hippocampus plays a vital role in sensorimotor processes and is therefore an area of 
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interest when investigating the neuropathology of schizophrenia (Morellini et al., 2007). 
Studies have detailed an alteration in hippocampal mossy fiber organization in CHL 1 
deficient mice irrespective of their background strain (Buhusi et al., 2003; Montag-Sallaz 
et al., 2002). Overall, there are many organizational changes in brain morphology when 
comparing CHL 1 deficient mice to their wild type littermates. Some of the axons in the 
CHL 1 deficient mice formed either small bundles or moved as individual thin mossy 
fibers through the CA3 region of the brain thereby forming a network between the 
suprapyramidal and infrapyramidal bundles. Many synaptic boutons surrounding the 
pyramidal cell soma were also observed (Montag-Sallaz et al., 2002). This indicates 
that terminals were formed on the cell bodies, not just the proximal part of the pyramidal 
cell dendrites. 
One study performed on 3 week old CHL 1 knockout mice showed an increase in 
the inhibitory postsynaptic currents evoked in pyramidal cells through minimal 
stimulation of perisomatically projecting interneurons. This study also observed that 
mice deficient in CHL 1 demonstrated age-dependent deficits in long term potentiation 
and perisomatic inhibition. These deficits became more pronounced with age (Dityatev 
et al., 2008). Projections to the dentate gyrus have been found to be enhanced in CHL 1 
deficient mice (Morellini et al., 2007). These enhanced projections may demonstrate 
the correlation between the altered behavioral response to environmental and social 
stimuli of CHL 1 knockout mice and the alterations in their brains. 
CHL 1 deficient mice also had alterations in their olfactory axon projections and 
thalamo-cortical neuroanatomy (Demyanenko et al., 2004). In addition, there is also a 
displacement of pyramidal neurons in layer V of the visual cortex (Demyanenko et al., 
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2004). Further observations of aberrant neuron migration in the olfactory bulbs of CHL 1 
deficient mice show that some of the axons either cross the glomerular layer without 
branching and terminate in the external plexiform layer, the underlying bulbar layer, or 
connect to more than one glomerulus (Montag-Sallaz et al., 2002). 
The temporary absence of CHL 1 results in some axonal ensembles and axons 
being incapable of finding the appropriate targets and the permanent absence of CHL 1 
is linked to misguided axonal projections and aberrant axonal connectivity (Montag-
Sallaz et al., 2002). These findings support the notion of the involvement of CHL 1 in 
psychiatric disorders such as schizophrenia as many of these abnormal brain structures 
are responsible for behaviors, such as sensory gating, that is impaired in schizophrenic 
patients (Braff et al., 2001; lrintchev et al., 2004). 
Behavioral Differences in CHL 1 Deficient Mice 
Mice deficient in CHL 1 have many abnormal behaviors when compared to wild 
type mice. The CHL 1 deficient mice react differently to open field tests, elevated plus 
maze tests, and Morris water maze tests. The deletion of the CHL 1 gene results in 
changes to other behavioral parameters such as motor coordination, delayed 
responsiveness to environmental stimuli, exploration, and stress alterations (Morellini et 
al., 2007; Pratte et al., 2003). In the open field test, CHL 1 deficient mice spent more 
time in the central area of the field as compared to their wild type littermates who tended 
to avoid the center of the field. This may indicate a different exploratory behavior of 
reduced anxiety. It is also speculated that CHL 1 deficient mice simply failed to notice 
the novelty of their environment in these tests and therefore explored all parts of the 
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field equally which would explain their reduced anxiety (Pratte et al., 2003). Knockout 
mice demonstrated milder reactions to stress inducing tests as well when compared to 
wild type mice, this behavior is commonly associated with the reduced anxiety in the 
open field test as shown in prior studies (Montag-Sallaz et al., 2002; Pratte et al., 2003). 
CHL 1 deficient mice also showed significant differences in terms of path swimming 
during the Morris water maze. CHL 1 deficient mice had similar swim patterns when 
compared to their wild type littermates, this suggests that spatial memory is not 
impaired by CHL 1 deficiency. However, on the first day of reversal, the mutants 
showed more crossing over the old goal, or perseveration, a trait commonly seen in 
schizophrenia that may relate to altered plasticity (Montag-Sallaz et al., 2002). 
Another study observed that CHL 1 deficient mice are impaired in prepulse 
inhibition which measures the ability of the central nervous system to gate the flow of 
sensory information (Dityatev et al., 2008). This impaired sensory-motor gating is often 
seen in schizophrenic patients (Braff et al., 2001; lrintchev et al., 2004). This study also 
implies that if CHL 1 is deficient at the intermediate stages of development, the deficit is 
compensated for; however, it appears later as impaired long term potentiation during 
the early and late stages of postnatal development (Dityatev et al., 2008). 
CHL 1 knockout mice have deficits in interval timing (Buhusi et al., 2003). Interval 
timing is necessary for decision-making and motor control. Impairments in interval 
timing have been observed in neuropsychiatric disorders, such as schizophrenia. CHL 1 
deficient mice show a maintained leftward shift in the response curve when compared to 
the responses of their wild type littermates. This means that the maximum response 
rate for CHL 1 deficient mice during a timing task occurred earlier than the peak 
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response rate for wild type mice. This indicates a deficit in their memory encoding and 
decoding capabilities (Buhusi et al., 2003). In a spatial-temporal task, CHL 1 deficient 
mice made more errors in working and reference memory than the controls. Timing 
impairments such as these have been reported in schizophrenia in numerous studies 
(Braus, 2002; Green and Nuechterlein, 1999; Herzog and Brand, 2009; Kimura, 2003; 
McDowell et al., 1996; Volz et al., 2001). These impairments may be due to the 
alterations in hippocampal circuitry. 
The purpose of this study was to assess the point mutation Leu17Phe in the 
signal peptide region of CHL 1 and determine the underlying mechanisms of 
pathogenecity that may contribute to the link between this mutation and schizophrenia. 
Methods 
In order to study the function of the point mutation resulting in the amino acid 
change of leucine to phenylalanine within the signal peptide region of CHL 1, we have 
decided to investigate the protein trafficking of CHL 1 on the cellular level. Studies 
investigating this mutation's effect on CHL 1 protein trafficking have not been conducted 
before and we hypothesize that this mutation in the signal peptide of CHL 1 will alter the 
protein's recruitment to the membrane thereby leading to the abnormal brain 
development seen in the schizophrenic patients. 
For this project, a plasmid called pcDNA3 with the wild type copy of the CHL 1 
gene already inserted into the multiple cloning site (MCS) at the EcoRI restriction site 
was used. This plasmid was transformed into XL 10 Gold E. coli cells in order to 
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produce a large stock of the plasmid. The plasmids were then isolated from the cells 
using a Qiagen Miniprep Kit. 
Site-directed mutagenesis was performed using polymerase chain reaction 
(PCR) with primers designed as per manufacturer protocol for the QuickChange II XL 
Mutagenesis Agilent Kit and based on the CHL 1 gene sequence found at NCBI in 
accession number AAHY01055945 (htt ://www.ncbi.nlm.nih. ov. These primers 
contain the single base change needed to alter the codon for leucine (CTC) to 
phenylalanine (TTC) within the CHL 1 signal peptide region (Table 1 ). 
Table 1. Sequences of Mutagenesis Primers 
Primer Sequence 
Forward 5' -tg ctg acaattttaa cag g aag aaaattag acttag g atcagtcc-3' 
Reverse 5'-ggactgatcctaagtctaattttcttcctgttaaaattgtcagca-3' 
After the PCR reaction, the new copies of the DNA should contain the mutation 
present in the primers. The linear PCR product is used to transform XL 10 Gold 
bacteria, which allows for the re-circularizing of the DNA obtained from the PCR. The 
bacteria were selected on Ampicillin LB Agar plates, plasmid DNA from selected clones 
was purified with Qiagen Miniprep kits and then sent to a commercial sequencing 
agency in order to evaluate the presence of the mutation as well as the accuracy of the 
rest of the sequence. Unfortunately, due to unforeseeable circumstances (plasmid DNA 
degraded due to Freezer failure) the mutation was not obtained. The rest of the project 




If the mutation occurs and the sequence is correct, both the wild type form of 
CHL 1 and the mutated CHL 1 gene (Leu17Phe) in the plasmid will undergo an additional 
PCR step for the amplification of the gene. In this PCR reaction, we will only be 
amplifying the CHL 1 cDNA (wild type or mutated depending on the plasmid). The 
appropriate restriction sites will be added to the gene with the promoter at this time as 
well. The CHL 1 sequence will be amplified without the stop codon. The PCR product 
will then be purified. The wild type and the mutated copies of CHL 1 will then be 
digested, or spliced, at the specific sites that were determined by our primer selection. 
For this project, an expression vector known as pTimer1 will be used. This 
vector contains a specific gene for a modified green fluorescent protein (GFP). When a 
gene of interest is ligated into the pTimer1 plasmid, it is inserted so that the genes fuse 
together. This way the expressed CHL 1 protein will contain the modified GFP at the C-
terminal end. The modified GFP, in this case DsRed1-E5, allows for easier observation 
of CHL 1 protein trafficking via microscopy. DsRed1-E5 is known as a modified GFP 
since when the protein is first expressed, it fluoresces in the green spectrum of light; 
however, as the protein ages, a red fluorophore emerges instead. This color shift from 
green to red is therefore useful in monitoring protein expression at the cell membrane 
as well as the rate of recycling and trafficking of new CHL 1 protein to the membrane. 
At this time in the experiment, we will also digest the pTimer1 plasmid with the 
same enzymes used to digest the CHL 1 mutant and wild type plasmids. The wild type 
gene can now be ligated into the digested pTimer1 plasmid and the mutated gene can 
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be ligated into another digested pTimer1 plasmid (a general outline of these steps can 
be found in figure 3.). These reactions will be put into XL 10 Gold bacteria again with a 
selective antibiotic in the plated LB agar in order to obtain recombinant clones. The 
bacteria that do not take up the plasmid will not be able to survive on these plates. A 
stock of these plasmids will be produced in XL 10 Gold and then the plasmids will be 
transfected into HEK293 cells along with lipofectamine which will produce a stable cell 
line. The success of these steps will create a new, workable way to study a novel 
mutation in the CHL 1 gene. Various studies, including CHL 1 signaling and protein 
recruitment differences, can be studied at a smaller level and can then be correlated to 






Figure 3. A general overview of the mutation of the CHL 1 gene and the movement of the wild 
type and mutated gene to the pTimer plasmid which allows for the comparison and observation 




We predict that the CHL 1 proteins with the mutated signal peptide will be 
trafficked less efficiently to the cell membrane, if at all, in comparison to the CHL 1 
proteins without the mutation. Therefore, we would expect the cells expressing the 
mutated signal sequence (Leu17Phe) in CHL 1 to have a membrane that is redder 
whereas the cells expressing the wild type CHL 1 would be greener (Figure 4). This is 
because the SRP is able to recognize the signal peptide on the CHL 1 wild type 
efficiently and therefore it is moved to the endoplasmic reticulum appropriately. This 
allows the recycling of the protein at the membrane to occur quickly, therefore the 
modified GFP is not expressed at the membrane long enough for us to see the shift 
from green absorption to red. The length of time necessary for the trafficking of CHL 1 
will be determined by preliminary observation of trafficking in CHL 1 WT cells. The GFP 
begins to turn red 3 hours after initial expression after which the shade of red deepens 
as the expression time lengthens. 
In juxtaposition, the mutated signal peptide should be more difficult for the SRP 
to recognize or may cause the machinery to sort the proteins incorrectly relocating the 
protein to another part of the cell. When the SRP cannot recognize the signal peptide, 
there will be no halt in translation of the mRNA by the ribosome. This may lead to the 
misfolding of the CHL 1 protein which would mark the protein for degradation, further 
emphasizing the necessity of a quick recognition response of the SRP for the signal 
peptide. If the SRP fails to recognize the mutant CHL 1 signal peptide there is an 
inhibition of protein recycling at the plasma membrane. Without this recycling, the 
CHL 1 with the modified GFP tag shifts from green to red as the protein ages. 
20 
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CHL 1 with WT Signal Peptide (SP) 
t 1 I • t • t • • 
t t • • 
Golgi stacks 





# Golgi stacks 
CHL1 old 
CHL 1 new 
CHL 1 WT SP new 
t CHL 1 WT SP old 
t CHL 1 mutant SP new 
• 
CHL 1 mutant SP old 
Figure 4. Expected recruitment of tagged CHL 1 to the cell membrane for both wild type and 
mutated CHL 1 proteins 
Discussion 
Unfortunately, the mutant CHL 1 plasmid was not obtained; therefore results are 
only speculated at this time. According to the literature currently available at this time 
we believe that a mutation within the signal peptide region of the CHL 1 protein would 
alter the trafficking of this protein. Based on the function of CHL 1 in the developing 
nervous system, we conclude that a disruption of CHL 1 trafficking could be an 
underlying factor in the brain morphology differences and aberrant axonal pathways and 
behaviors witnessed in patients diagnosed with schizophrenia. Due to this lack of 
results, however, these conclusions still remain as solely speculations. A new CHL 1 
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wild type plasmid has been obtained in order to repeat procedures in the hopes that the 
leucine to phenylalanine mutation may be created and studied. 
There are a few speculations as to why we did not achieve the CHL 1 mutant. A 
nanodrop test of the sterile water revealed that the molecular grade water had been 
contaminated and exhibited absorbance patterns similar to protein and nucleoside 
contamination. Another possible error could be due to a freezer issue experienced 
prior to the start of the experiment. At that time, the wild type CHL 1 plasmid was being 
stored in the -80°C freezer. The power supply to that freezer failed and the backup 
generator did not initiate. Therefore the plasmid experienced a drop in temperature for 
an undetermined period of time, this could have resulted in nicks within the CHL 1 
plasmid DNA. 
In an attempt to fix these nicks, the CHL 1 plasmid DNA was moved into XL 10-
Gold E. coli, which are bacteria commonly characterized by their ability to fill in nicked 
DNA. However, since we still did not obtain the mutant CHL 1, it is unsure whether or not 
the bacteria were actually able to fix the nicked DNA. Gel electrophoresis was ran on 
the wild type CHL 1 plasmid to view whether or not the plasmid DNA was in pieces or 
cohesive. The gel showed one large band at the appropriate size for the CHL 1 wild 
type plasmid suggesting the DNA is not nicked but may still contain damage that makes 
it nonfunctional. Therefore, we believe the best measure to take at this time would be to 




CHL 1 is a vital protein for the appropriate development of the nervous system; 
however, this protein remains understudied and its function is not well understood. 
Therefore, continued research on this protein is essential for understanding the 
mechanisms of many diseases such as schizophrenia as well as providing more 
knowledge on how the nervous system develops. Studies previously done have 
identified CHL 1 as an important contributor in many behavioral paradigms (Baddeley 
and Salame, 1986; Braff et al., 2001; lrintchev et al., 2004; Kolata et al., 2008; Morellini 
et al., 2007). When the CHL 1 gene is knockout, mice exhibit altered emotional 
reactivity and motor coordination, as well as reduced sensorimotor gating, impaired 
working and spatial-integration. These abnormal behaviors may be linked to the altered 
brain morphology in CHL 1 knockout mice wherein there are alterations to axonal 
guidance leading to inappropriate neuronal connections particularly in the hippocampal 
regions during development (Montag-Sallaz et al., 2002). 
Continued attempts to achieve the correct missense polymorphism will be made 
and the study will be completed at a later time. This research will continue based on 
whether or not the expected results are achieved. If there is shown to be a significant 
difference in the recruitment of the mutated CHL 1 to the membrane between the mutant 
and the wild type, then further studies may be done to better understand the underlying 
mechanism. In particular, a new mouse model could be made that expresses this 
mutant CHL 1 (Leu17Phe). This model could then be used to study the behavioral 
effects of the point mutation. If the mutant CHL 1 is not recruited differently in 
comparison to the wild type cells, further research would involve choosing another point 
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mutation to investigate. The study done by Sakurai et al. identified other mutations in 
the CHL 1 gene among the schizophrenic population that could also be studied (Sakurai 




Overall, I think that my thesis experience was essential to my undergraduate 
degree. I feel like I have learned the most from my thesis in comparison to the rest of 
my course material. By doing this thesis project, I was able to apply the knowledge I 
have learned in my biology and chemistry coursework to a real life research experience. 
Although the project was a bit frustrating at times, I was able to develop valuable skills 
in troubleshooting problems that arose throughout the experiment. I have gained a lot 
of respect and appreciation for researchers and the scientific community in general from 
doing this project. 
There were a few problems faced while working on this thesis. The agar plates 
after a 24 hour incubation period would be found cracked and dried up. The 
temperature of the incubator was checked and held steady at 37°C, so it was 
determined that that was not the issue. After adding some water to the incubator while 
the plates were incubating, the shrinkage did appear to slow down somewhat but did 
not stop overall. I also checked to ensure that none of the liquid evaporated from the 
agar solution during the liquid autoclaving which ultimately result in a higher 
concentration. The final thought process was to change the agar mixture brand. This 
did seem to help and we did not have issues with the agar drying out after this, although 
during this time there was also a lot of rain which did raise the overall humidity in the lab 
so we cannot determine that this was a complete fix. 
Another issue that we faced was being unable to achieve a sequence for the 
clones sent in for sequencing. There are a couple of factors that could have contributed 
to this issue. A sample of primer and water was analyzed via nanodrop and was 
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determined to have been contaminated. This contributed to the larger problem in the 
sequencing as the clones were diluted using the contaminated molecular grade water 
and the sequencing was run using the primers made from the contaminated water. 
Also, many of the clones' DNA were really low in concentration even after utilizing 
minipreps. In order to resolve this problem, less water was used at the end to elute the 
DNA which did bring the concentration up slightly, however, did not yield as high of a 
concentration as expected. A final factor that we are now investigating is a problem 
with the freezers that occurred before the project started. At that time, the -80°C freezer 
went down for a while with no power, therefore the stock wild type plasmid that was 
being stored in this freezer warmed up for an indeterminate amount of time. This may 
have caused nicking in the DNA that would have deemed the plasmid useless for use in 
the project. Although we attempted to check that the plasmid was not nicked (using gel 
electrophoresis) and tried to fix any nicks that did occur (by placing the plasmid in XL 10-
Gold E. coli-bacteria that is known for their ability to re-circularize DNA and fix DNA 
nicks), the fact that a clone was not achieved means that this could still be a problem. 
In order to troubleshoot this factor, a new CHL 1 wild type plasmid was obtained from 
another laboratory. Testing on this plasmid has not yet been conducted, ergo, we 
cannot yet determine if this is the solution or not. 
The literature review portion of the thesis was very interesting but also incredibly 
overwhelming. There is a lot of research being done within the field which makes it 
difficult to narrow down which articles will be most applicable to this research and will 
contribute to a cohesive paper. During this research, I was impressed by how many 
different ways people were researching similar ideas. The amount of methods out there 
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is astounding. I used to be under the impression that there were not a lot of new things 
to discover, but in reading these articles, so many researchers are investigating different 
paths for the same main idea. This has really opened my eyes to all of the possibilities 
for research out there. A lot of the mechanisms underlying the necessary functions of 
life are still unknown which makes the prospects of research all the more appealing to 
me. 
Ultimately, this thesis project has been very beneficial to my undergraduate 
career. I was able to learn how to troubleshoot problems that occur during research 
and use the resources around me (such as other researchers, mentors, and the 
internet) to my advantage. I was also able to improve my ability to read and 
understand scientific literature. I enjoyed being able to use knowledge from my 
undergraduate courses in order to actually understand how genes and proteins function 
and how alterations to a gene can lead to drastic changes in the organism. These 
mutations can alter protein trafficking, gene expression, amino acid association-which 
ultimately alters protein form and furthermore its function, and many other processes 
within the cell. Even though I did not receive results for this experiment, I learned a lot 
from this experiment. I feel like I am now more prepared to handle problems that may 
arise in a laboratory setting after my experience with this thesis. Being capable of 
handling these situations is paramount to my career as a scientist and so I believe that I 
am much better suited for a research environment now then I was when I first started 
my thesis. I also learned a lot about the CHL 1 protein which I thought was a lot of fun to 
know about in detail and to see it functioning as a specific example of many of the 
processes that I have learned about throughout my coursework like the use of a signal 
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peptide sequence in protein trafficking. I definitely benefited from my experience with 
this project and paper and will be able to draw from my experiences in later years when 
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